drug · small molecule
patient view →IDELALISIB
Marketedupdated 2mo agoby $GILD GILEAD SCIENCES, INC.🔗 ChEMBL
Approvedcommunity read0 votes
Small molecule drug with a maximum clinical stage of Approval (across all indications), with 5 approved and 10 investigational indications.
targets
Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform
all catalysts(1)
approval · 1
News(0)
no news has mentioned this drug yet
comments(0)
5-min edit window · permanent after that